Lv11
96 积分 2025-12-17 加入
Comparison of clinical efficacy and safety of weekly glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel-group, multicentre, open-label trial (COMING study)
23分钟前
待确认
Effect of the exenatide plus dapagliflozin combination on fatty liver index and insulin resistance in type 2 diabetes patients: the DURATION-8 trial
3小时前
求助中
皖公网安备34019202002308
